Corient Private Wealth LP acquired a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 705,975 shares of the conglomerate’s stock, valued at approximately $134,475,000.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Palogic Value Management L.P. acquired a new position in shares of Danaher during the second quarter valued at $216,000. Perennial Investment Advisors LLC bought a new position in shares of Danaher during the second quarter worth about $216,000. Permanens Capital L.P. acquired a new stake in shares of Danaher in the 2nd quarter worth about $1,908,000. Pingora Partners LLC bought a new stake in Danaher in the 2nd quarter valued at about $190,000. Finally, Ausdal Financial Partners Inc. bought a new stake in Danaher in the 2nd quarter valued at about $467,000. 79.05% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have commented on DHR shares. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. Royal Bank Of Canada lifted their price target on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Citigroup began coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Finally, Guggenheim cut their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.
Danaher Stock Down 0.0%
Danaher stock opened at $215.90 on Thursday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market cap of $151.77 billion, a price-to-earnings ratio of 38.35, a PEG ratio of 2.69 and a beta of 0.78. The company’s 50-day moving average price is $197.93 and its two-hundred day moving average price is $192.36. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm posted $0.77 earnings per share. The business’s revenue was up 5.5% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
